Delivery Order SPE2DB20D7066-SPE2DB25FC4SQ
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $60,767.26 for 100 mg vials of Activase on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,875.45 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed-price contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,595.40 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,730.80 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency awarded a $35.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Activase 100 mg vials, with completion scheduled for September 10, 2025. The contract is unclassified as a set-aside and represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,676.32 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $21,231.29 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of Activase 50 mg vials valued at $3,207.38. This non-set-aside, competitively awarded contract features firm fixed pricing and an ultimate completion date of August 6, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense, and is being performed at the...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials valued at $3,351.48. This contract was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The award was made competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. This...